&lt;p&gt;The Human Genetic Variants CYP2J2 rs2280275 and EPHX2 rs751141 and Risk of Diabetic Nephropathy in Egyptian Type 2 Diabetic Patients&lt;/p&gt;

Habieb, Mona S.; Dawood, Ashraf; Emara, Mahmoud; Elhelbawy, Mohammad G.; Elhelbawy, Nesreen G

doi:10.2147/tacg.s281502

Cited by 7 publications

(6 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study indicated that enriched genes might play important role in PCOS. As previously reported, FOXP3 [446], TIMP4 [447], OAS3 [448], SOCS1 [128], CD74 [129], PLK1 [449], TGFB1 [450], RAPGEF1 [451], SERPINH1 [452], ATF5 [66], GATA6 [133], IGF2BP1 [453], IRX3 [454], FOXC2 [455], SNHG17 [456], TAF1C [457], HHIP (hedgehog interacting protein) [458], POMC (proopiomelanocortin) [459], DOK5 [76], COL1A1 [460], POSTN (periostin) [461], SOD3 [462], ADAMTS13 [463], FABP5 [464], MAPK11 [465], KCTD15 [83], HSPG2 [466], MST1 [467], MGAT2 [468], LGR5 [469], SPINK1 [470], CYP19A1 [471], PLAC8 [90], CD36 [472], AQP5 [473], GIPR (gastric inhibitory polypeptide receptor) [474], ARG1 [475], SORL1 [476], CD4 [477], F11R [478], LEPR (leptin receptor) [479], CDH13 [480], AR (androgen receptor) [481], FOXO1 [102], MALT1 [482], PAM (peptidylglycine alpha-amidating monooxygenase) [483], B2M [484], TCF4 [485], CAV2 [486], HSBP1 [487], COLEC12 [488], ADRA2A [489], SLC38A4 [490], TM6SF2 [491], GLP2R [111], KLB (klotho beta) [492], NFAT5 [493], PON2 [494], ZMAT3 [495], DST (dystonin) [426], MGST3 [496], COQ2 [118], EPHX2 [497], C2 [181] and FAM3C [120] are altered expression in type 2 diabetes mellitus. Previous studies have shown that DRD4 [498], TIMP4 [499], SOCS1 [500], CD74 [501], TGFB1 [502], ACTG2 [503], ISG15 [504], HOXC8 [...…”

Section: Discussionmentioning

confidence: 99%

The Identification of Key Genes and Biological Pathways in Polycystic Ovary Syndrome and its Complications by Next Generation Squancing (NGS) and Bioinformatics Analysis

Vastrad¹,

Vastrad²

2023

Preprint

View full text Add to dashboard Cite

Polycystic ovary syndrome (PCOS) is is associated with infertility, obesity, insulin resistance, hyperinsulinemia, type 2 diabetes mellitus, hypertension, cardiovascular problems, neurological and psychological problems and cancer. The specific mechanism of PCOS and its complications remains unclear. The aim of this study was to apply a bioinformatics approach to reveal related pathways or genes involved in the development of PCOS and its complications. The next generation squancing (NGS) datset GSE199225 was downloaded from the gene expression omnibus (GEO) database. Differentially expressed gene (DEG) analysis was performed using DESeq2. The g:Profiler was utilized to analyze the functional enrichment, gene ontology (GO) and REACTOME pathway of the differentially expressed genes. A protein-protein interaction (PPI) network was constructed and module analysis was performed using HiPPIE and cytoscape. The miRNA-hub gene regulatory network and TF-hub gene regulatory network were also constructed for research. The expression of the hub genes was validated using receiver operating characteristic (ROC) curve analysis. We have identified 957 DEGs in total, including 478 up regulated genes and 479 down regulated gene. GO and REACTOME illustrated that DEGs in PCOS were significantly enriched in regulation of molecular function, developmental process, interferon signaling and platelet activation, signaling and aggregation. Finally, through analyzing the PPI network, modules, miRNA-hub gene regulatory network and TF-hub gene regulatory network, we screened hub genes HSPA5, PLK1, RIN3, DBN1, CCDC85B, DISC1, AR, MTUS2, LYN and TCF4 by the Cytoscape software. This study uses a series of bioinformatics technologies to obtain hug genes and key pathways related to PCOS and its complications. These analysis results provide us with novel ideas for finding biomarkers and treatment methods for PCOS and its complications.

show abstract

Section: Discussionmentioning

confidence: 99%

The Identification of Key Genes and Biological Pathways in Polycystic Ovary Syndrome and its Complications by Next Generation Squancing (NGS) and Bioinformatics Analysis

Vastrad¹,

Vastrad²

2023

Preprint

View full text Add to dashboard Cite

show abstract

“…Gene deletion and pharmacological inhibition of EPHX2 exhibit an increase in insulin sensitivity in a T2DM rodent model [85]. Furthermore, its variants are likely to be associated with neuropathy in T2DM patients [86]. EPHX2 circulating levels are elevated in obese individuals and its expression is attenuated after physical activity in both adipose tissue and peripheral blood mononuclear cells [87].…”

Section: Discussionmentioning

confidence: 99%

Changes in the Proteome Profile of People Achieving Remission of Type 2 Diabetes after Bariatric Surgery

Iqbal

Fachim

Gibson

et al. 2021

JCM

View full text Add to dashboard Cite

Bariatric surgery (BS) results in metabolic pathway recalibration. We have identified potential biomarkers in plasma of people achieving type 2 diabetes mellitus (T2DM) remission after BS. Longitudinal analysis was performed on plasma from 10 individuals following Roux-en-Y gastric bypass (n = 7) or sleeve gastrectomy (n = 3). Sequential window acquisition of all theoretical fragment ion spectra mass spectrometry (SWATH-MS) was done on samples taken at 4 months before (baseline) and 6 and 12 months after BS. Four hundred sixty-seven proteins were quantified by SWATH-MS. Principal component analysis resolved samples from distinct time points after selection of key discriminatory proteins: 25 proteins were differentially expressed between baseline and 6 months post-surgery; 39 proteins between baseline and 12 months. Eight proteins (SHBG, TF, PRG4, APOA4, LRG1, HSPA4, EPHX2 and PGLYRP) were significantly different to baseline at both 6 and 12 months post-surgery. The panel of proteins identified as consistently different included peptides related to insulin sensitivity (SHBG increase), systemic inflammation (TF and HSPA4—both decreased) and lipid metabolism (APOA4 decreased). We found significant changes in the proteome for eight proteins at 6- and 12-months post-BS, and several of these are key components in metabolic and inflammatory pathways. These may represent potential biomarkers of remission of T2DM.

show abstract

“…Lower insulin sensitivity and higher fasting insulin levels were also observed among the His139/His139 genotype carriers comparing with Arg139 allele carriers [ 168 ]. It has been also reported that EPHX2 rs751141 A allele was protective against diabetic nephropathy among Egyptian T2DM cases [ 169 ].…”

Section: Introductionmentioning

confidence: 99%

Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population

et al. 2022

View full text Add to dashboard Cite

Diabetes is a chronic metabolic disorder that leads to the dysfunction of various tissues and organs, including eyes, kidneys, and cardiovascular system. According to the World Health Organization, diabetes prevalence is 8.8% globally among whom about 90% of cases are type 2 diabetes. There are not any significant clinical manifestations in the primary stages of diabetes. Therefore, screening can be an efficient way to reduce the diabetic complications. Over the recent decades, the prevalence of diabetes has increased alarmingly among the Middle East population, which has imposed exorbitant costs on the health care system in this region. Given that the genetic changes are among the important risk factors associated with predisposing people to diabetes, we examined the role of single-nucleotide polymorphisms (SNPs) in the pathogenesis of diabetes among Middle East population. In the present review, we assessed the molecular pathology of diabetes in the Middle East population that paves the way for introducing an efficient SNP-based diagnostic panel for diabetes screening among the Middle East population. Since, the Middle East has a population of 370 million people; the current review can be a reliable model for the introduction of SNP-based diagnostic panels in other populations and countries around the world.

show abstract

<p>The Human Genetic Variants CYP2J2 rs2280275 and EPHX2 rs751141 and Risk of Diabetic Nephropathy in Egyptian Type 2 Diabetic Patients</p>

Cited by 7 publications

References 42 publications

The Identification of Key Genes and Biological Pathways in Polycystic Ovary Syndrome and its Complications by Next Generation Squancing (NGS) and Bioinformatics Analysis

The Identification of Key Genes and Biological Pathways in Polycystic Ovary Syndrome and its Complications by Next Generation Squancing (NGS) and Bioinformatics Analysis

Changes in the Proteome Profile of People Achieving Remission of Type 2 Diabetes after Bariatric Surgery

Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population

Contact Info

Product

Resources

About